Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check11 days agoChange DetectedThe record history shows a new revision tag v3.6.2, replacing v3.6.0. It indicates a page-level update rather than substantive changes to study data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment is closed (no longer looking for participants), indicating enrollment has ended. The history also shows a new page revision to v3.6.0, with the prior v3.5.5 entry removed.SummaryDifference0.5%

- Check32 days agoChange DetectedA new revision tag, v3.5.5, was added to the Record History, signaling a newer version of the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study record shows termination and updated recruitment status, indicating that active enrollment has ended. The version history adds new entries such as a document section and study design dated 2026-05-19 and 2026-05-22 to document these changes.SummaryDifference0.8%

- Check54 days agoChange DetectedRevision: v3.5.4 was added to the page history, replacing v3.5.3. This indicates a new revision of the study record in ClinicalTrials.gov's history log.SummaryDifference0.1%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.